<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="lipoid-p" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">lipoid-p</book-part-id>
      <title-group>
        <title>Lipoid Proteinosis</title>
        <alt-title alt-title-type="alt-title">Synonyms: Hyalinosis Cutis et Mucosae, Urbach-Wiethe Disease</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vahidnezhad</surname>
            <given-names>Hassan</given-names>
          </name>
          <degrees>MSc</degrees>
          <aff>Molecular Medicine Division<break/>Biotechnology Research Center<break/>Pasteur Institute of Iran<break/>Tehran, Iran <break/>Department of Dermatology and Cutaneous Biology<break/>Sidney Kimmel Medical College<break/>Thomas Jefferson University<break/>Philadelphia, Pennsylvania</aff>
          <email>Hassan_Vahidnezhad@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Youssefian</surname>
            <given-names>Leila</given-names>
          </name>
          <degrees>MSc</degrees>
          <aff>Department of Dermatology and Cutaneous Biology<break/>Sidney Kimmel Medical College<break/>Thomas Jefferson University<break/>Philadelphia, Pennsylvania</aff>
          <email>Leila.Youssefian@jefferson.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Uitto</surname>
            <given-names>Jouni</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Dermatology and Cutaneous Biology<break/>Sidney Kimmel Medical College<break/>Thomas Jefferson University<break/>Philadelphia, Pennsylvania</aff>
          <email>Jouni.Uitto@jefferson.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2016-01-21" date-type="created">
          <day>21</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="loeys-dietz" document-type="chapter">Loeys-Dietz Syndrome</related-object>
      <abstract id="lipoid-p.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Lipoid proteinosis (LP) is characterized by deposition of hyaline-like material in various tissues resulting in a hoarse voice from early infancy, vesicles and hemorrhagic crusts in the mouth and on the face and extremities, verrucous and keratotic cutaneous lesions on extensor surfaces (especially the elbows), and moniliform blepharosis (multiple beaded papules along the eyelid margins and inner canthus). Extra cutaneous manifestations may include epilepsy, neuropsychiatric disorders, and spontaneous CNS hemorrhage. Males and females are affected equally. Generally, the disease course is chronic and fluctuating. Affected individuals have a normal life span unless they experience laryngeal obstruction.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of lipoid proteinosis is established in a proband with characteristic clinical findings and either identification of biallelic <italic toggle="yes">ECM1</italic> pathogenic variants on molecular genetic testing or characteristic histologic and/or immuno-labeling findings on skin biopsy.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: There are no proven treatments for the skin lesions. Microlaryngoscopic excision of laryngeal deposits can improve airway access and voice quality. Significant airway obstruction may require tracheostomy to ensure a safe airway. Seizures should be assessed and managed by a neurologist, using antiepileptic drugs (AEDs).</p>
          <p><italic toggle="yes">Surveillance</italic>: Routine follow-up of children to monitor general health as well as psychomotor, emotional, and cognitive development. Monitoring of the airway and vocal cords by an otolaryngologist.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>LP is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible when the <italic toggle="yes">ECM1</italic> pathogenic variants in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="lipoid-p.Diagnosis">
        <title>Diagnosis</title>
        <sec id="lipoid-p.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Lipoid proteinosis (LP), which is characterized by deposition of hyaline-like material in the larynx, oral cavity, skin, and internal organs, <bold>should be suspected</bold> in individuals with the following clinical manifestations and findings on neuroimaging.</p>
          <p><bold>Clinical manifestations</bold> (in order of their importance for diagnosis)</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Hoarse voice.</bold> The first manifestation in almost all individuals is a weak cry or hoarse voice (due to infiltration and deposition of hyaline-like material in the vocal cords)appearing during the first year of life, and often in early infancy. Hoarseness usually persists lifelong [<xref ref-type="bibr" rid="lipoid-p.REF.savage.1988.33">Savage et al 1988</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Moniliform blepharosis,</bold> a pathognomonic sign, is the presence of multiple beaded papules along the eyelid margins and inner canthus (<xref ref-type="fig" rid="lipoid-p.F1">Figure1d,e</xref>) [<xref ref-type="bibr" rid="lipoid-p.REF.belliveau.2015.e150688">Belliveau et al 2015</xref>].The papular infiltration can be quite subtle in some individuals.</p>
            </list-item>
            <list-item>
              <p><bold>Cutaneous findings</bold> (appearing in two overlapping stages):</p>
              <list list-type="bullet">
                <list-item>
                  <p>First, vesicles and hemorrhagic crusts, often caused by minor trauma or friction, appear in the mouth and on the face and extremities (<xref ref-type="fig" rid="lipoid-p.F1">Figure1a</xref>). Vesicles can be one of the earliest clinical manifestations in up to 50% of affected neonates.</p>
                </list-item>
                <list-item>
                  <p>Later, with increasing hyaline deposition in the dermis, the skin becomes diffusely thickened and appears waxy with a yellowish discoloration; papules, nodules, and plaques appear on the face and lips (<xref ref-type="fig" rid="lipoid-p.F1">Figure1d</xref>). Verrucous and keratotic cutaneous lesions may develop on extensor surfaces, especially the elbows (<xref ref-type="fig" rid="lipoid-p.F1">Figure1f</xref>) [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2002.624">Hamada 2002</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Central nervous system and neuropsychiatric manifestations</bold> commonly include epilepsy (predominantly temporal lobe variant) and behavioral manifestations (memory impairment, paranoia, aggressive behavior, hallucinations, and absence of fear) [<xref ref-type="bibr" rid="lipoid-p.REF.siebert.2003.2627">Siebert et al 2003</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.thornton.2008.86">Thornton et al 2008</xref>] in association with calcification of the temporal lobes or hippocampi (<xref ref-type="fig" rid="lipoid-p.F1">Figure1h</xref>).</p>
            </list-item>
            <list-item>
              <p><bold>Ear-nose-throat.</bold> Infiltration of the mucosae of the pharynx, tongue, soft palate, tonsils, and lips may lead to upper respiratory tract infections as well as recurrent episodes of parotitis (caused by stenosis of the parotid duct), submandibular gland inflammation, and poor dental health. The tongue may be short; thickening of the frenulum may result in difficulty protruding the tongue (<xref ref-type="fig" rid="lipoid-p.F1">Figure1c</xref>) [<xref ref-type="bibr" rid="lipoid-p.REF.chan.2007.881">Chan et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Hair and nails</bold>. Patchy alopecia of the scalp, beard, eyelashes, and eyebrows as well as nail dystrophy are present in some [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2002.624">Hamada 2002</xref>].Note: Clinical findings may vary among affected individuals within the same family or population isolate, including presence of neurologic abnormalities in the absence of skin manifestations [<xref ref-type="bibr" rid="lipoid-p.REF.youssefian.2015.220">Youssefian et al 2015</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Neuroimaging</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Brain CT.</bold> Brain CT readily detects mineral deposits (i.e., intracranial calcifications); in some it reveals circumscribed, horn-shaped bilateral symmetric calcifications.</p>
            </list-item>
            <list-item>
              <p><bold>Brain MRI.</bold> Although brain MRI can provide better anatomic details than CT, it is less sensitive in detecting calcification (<xref ref-type="fig" rid="lipoid-p.F1">Figure1h</xref>) [<xref ref-type="bibr" rid="lipoid-p.REF.siebert.2003.2627">Siebert et al 2003</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.chan.2004.151">Chan et al 2004</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.thornton.2008.86">Thornton et al 2008</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.gon_alves.2010.88">Gon&#x000e7;alves et al 2010</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="lipoid-p.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of lipoid proteinosis <bold>is established</bold> in a proband with characteristic clinical findings and EITHER of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Identification of biallelic <italic toggle="yes">ECM1</italic> pathogenic variants on molecular genetic testing [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2002.833">Hamada et al 2002</xref>] (see <xref ref-type="table" rid="lipoid-p.T.molecular_genetic_testing_use">Table 1</xref>)</p>
            </list-item>
            <list-item>
              <p>Characteristic histologic findings and/or immuno-labeling on skin biopsy (see <bold>Skin biopsy</bold>).</p>
            </list-item>
          </list>
          <p>Molecular testing approaches can include <bold>single-gene testing,</bold> use of a <bold>multi-gene panel,</bold> and <bold>more comprehensive</bold>
<bold>genomic testing.</bold></p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">ECM1</italic>is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">ECM1</italic> and other genes of interest (see <xref ref-type="sec" rid="lipoid-p.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> including &#x02013; when available &#x02013; whole-exome sequencing (WES) and whole-genome sequencing (WGS) may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">ECM1</italic>) fails to confirm a diagnosis in an individual with features of lipoid proteinosis. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="lipoid-p.T.molecular_genetic_testing_use" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Lipoid Proteinosis</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_lipoid-p.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_lipoid-p.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_lipoid-p.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_lipoid-p.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">ECM1</italic>
                  </td>
                  <td headers="hd_h_lipoid-p.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup><hr/></td>
                  <td headers="hd_h_lipoid-p.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">More than 95%&#x000a0;<sup>4</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_lipoid-p.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_lipoid-p.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="lipoid-p.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="lipoid-p" object-id="lipoid-p.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="lipoid-p.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="lipoid-p.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="lipoid-p.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="lipoid-p.TF.1.4">
                <label>4. </label>
                <p>Nearly 50% of all pathogenic variants occur in exons 6 and 7 in all populations [<xref ref-type="bibr" rid="lipoid-p.REF.chan.2007.881">Chan et al 2007</xref>].</p>
              </fn>
              <fn id="lipoid-p.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="lipoid-p.TF.1.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available. Gross deletions have been reported in two cases [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2002.833">Hamada et al 2002</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.lee.2015a.608">Lee et al 2015a</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>
            <bold>Skin biopsy</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Hematoxylin and eosin (H&#x00026;E) staining shows hyperkeratosis and accumulation of hyaline-like material in the dermis.</p>
            </list-item>
            <list-item>
              <p>Periodic acid-Schiff (PAS)-diastase staining shows PAS-positive, diastase-resistant basement membrane thickening and reduplication at the dermal-epidermal junction around blood vessels [<xref ref-type="bibr" rid="lipoid-p.REF.moy.1987.1193">Moy et al 1987</xref>].</p>
            </list-item>
            <list-item>
              <p>Immuno-labeling using polyclonal anti-ECM1 antibody shows reduced levels of ECM1 protein, providing a means of rapid diagnosis especially in the early stages of the disease [<xref ref-type="bibr" rid="lipoid-p.REF.chan.2004.151">Chan et al 2004</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="lipoid-p.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="lipoid-p.Clinical_Description">
          <title>Clinical Description</title>
          <p>Lipoid proteinosis (LP) is characterized by deposition of hyaline-like material that results in a hoarse voice from early infancy, vesicles and hemorrhagic crusts in the mouth and on the face and extremities induced by minor trauma, verrucous and keratotic cutaneous lesions on extensor surfaces (especially the elbows), and moniliform blepharosis (multiple beaded papules along the eyelid margins and inner canthus).</p>
          <p>Generally, LP follows a chronic and fluctuating course. Males and females are affected equally. Affected individuals have a normal life span unless they experience laryngeal obstruction.</p>
          <p>A hoarse voice, often evident at birth or early infancy as a weak cry, is present in essentially all individuals with LP and usually persists lifelong and can progress to severe dysphonia and/or complete aphonia [<xref ref-type="bibr" rid="lipoid-p.REF.savage.1988.33">Savage et al 1988</xref>]. In addition, involvement of the mucosae of the pharynx, soft palate, tonsils, and lips may lead to pulmonary manifestations, especially upper-respiratory tract infection. In some cases, infiltration of the laryngeal mucosa may lead to breathing difficulties.</p>
          <p>Recurrent episodes of parotitis caused by stenosis of the parotid duct and submandibular gland inflammation are reported. Infiltration of the tongue may destroy the dorsal papillae, causing the tongue to have a smooth surface.</p>
          <p>Dental health is often poor [<xref ref-type="bibr" rid="lipoid-p.REF.savage.1988.33">Savage et al 1988</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.chan.2007.881">Chan et al 2007</xref>].</p>
          <p>The skin lesions usually progress during the first few years of life in two overlapping stages:</p>
          <list list-type="bullet">
            <list-item>
              <p>During childhood the skin may be easily damaged by minor trauma or friction, resulting in blisters and scar formation. Pock-like or acneiform scars, vesicles, and hemorrhagic crust are particularly evident on the face and extremities (<xref ref-type="fig" rid="lipoid-p.F1">Figure1a</xref>).</p>
            </list-item>
            <list-item>
              <p>At later stages with increasing hyaline-like deposition within the dermis, skin becomes diffusely thickened and appears waxy with yellowish discoloration; papules, nodules, and plaques appear on the face and the lips (<xref ref-type="fig" rid="lipoid-p.F1">Figure1d</xref>).</p>
            </list-item>
          </list>
          <p>Hyperkeratotic and verrucous lesions may appear in regions exposed to mechanical trauma, such as the hands, elbows, knees, buttocks, and axillae (<xref ref-type="fig" rid="lipoid-p.F1">Figure 1b,f,g</xref>) [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2002.624">Hamada 2002</xref>].</p>
          <p>Patchy and diffuse alopecia of the scalp, beard, eyelashes, and eyebrows may be present; however, alopecia is not a significant finding in most. Nail dystrophy has been reported [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2002.624">Hamada 2002</xref>].</p>
          <p>Extracutaneous manifestations may include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Epilepsy</bold>. Seizure onset may be in childhood or adulthood. Temporal lobe epilepsy is the most common type, with both partial and (less frequently) secondarily generalized seizures observed. Seizures may be therapy-resistant [<xref ref-type="bibr" rid="lipoid-p.REF.claeys.2007.465">Claeys et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Neuropsychiatric disorders</bold> can include impairment of day-to-day memory (but not distant memory), paranoia, aggressive behavior and rage, hallucinations, absence of fear, and lack of normal sense of distrust or danger. Neuropsychiatric disorders can appear in childhood and are progressive. Individuals with lipoid proteinosis perform poorly on facial recognition of positive and negative emotions. These neuropsychiatric manifestations sometimes occur in association with calcification in the temporal lobes in the region of the amygdalae (<xref ref-type="fig" rid="lipoid-p.F1">Figure1h</xref>) [<xref ref-type="bibr" rid="lipoid-p.REF.siebert.2003.2627">Siebert et al 2003</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.thornton.2008.86">Thornton et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Spontaneous CNS hemorrhage</bold> (including small deep brain hemorrhages and large brain hematomata) has been reported and can lead to hemiparesis and hemiplegia [<xref ref-type="bibr" rid="lipoid-p.REF.siebert.2003.2627">Siebert et al 2003</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.messina.2012.1740">Messina et al 2012</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.teive.2013.1720">Teive et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Gastrointestinal bleeding.</bold> Multiple yellowish nodules can be found throughout the esophagus, stomach, duodenum, and colon, and are usually asymptomatic [<xref ref-type="bibr" rid="lipoid-p.REF.cust_dio_lima.2014">Cust&#x000f3;dio Lima et al 2014</xref>]; however, small intestinal bleeding has been observed in one individual [<xref ref-type="bibr" rid="lipoid-p.REF.caccamo.1994.572">Caccamo et al 1994</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="lipoid-p.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No apparent <italic toggle="yes">ECM1</italic> genotype&#x02013;phenotype correlations are evident [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2003.345">Hamada et al 2003</xref>]. A wide range of clinical manifestations and disease progression (termed variable expressivity) occurs in individuals with the same <italic toggle="yes">ECM1</italic> pathogenic variants even within the same family or population isolate [<xref ref-type="bibr" rid="lipoid-p.REF.youssefian.2015.220">Youssefian et al 2015</xref>].</p>
        </sec>
        <sec id="lipoid-p.Prevalence">
          <title>Prevalence</title>
          <p>Fewer than 500 individuals with lipoid proteinosis (LP) have been reported worldwide.</p>
          <p>LP tends to be more common in countries with extensive consanguinity and/or in areas (e.g., South Africa) in which a founder variant has been postulated [<xref ref-type="bibr" rid="lipoid-p.REF.van_hougenhoucktulleken.2004.413">Van Hougenhouck-Tulleken et al 2004</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.chan.2007.881">Chan et al 2007</xref>].</p>
        </sec>
      </sec>
      <sec id="lipoid-p.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">ECM1</italic>.</p>
      </sec>
      <sec id="lipoid-p.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><related-object link-type="booklink" source-id="gene" document-id="epp-ar" document-type="chapter"><bold>Erythropoietic protoporphyria</bold></related-object>
<bold>(EPP)</bold> is characterized by cutaneous photosensitivity (usually beginning in infancy or childhood) that results in tingling, burning, pain, and itching within minutes of sun/light exposure and may be accompanied by swelling and redness. Blistering is uncommon. Symptoms (which may seem out of proportion to the visible skin lesions) may persist for hours or days after the initial phototoxic reaction. Photosensitivity usually remains for life. Multiple episodes of acute photosensitivity may lead to chronic changes of sun-exposed skin (lichenification, leathery pseudo-vesicles, grooving around the lips) and loss of lunulae of the nails. Approximately 20%-30% of individuals with EPP have some degree of liver dysfunction, which is typically mild with slight elevation of the liver enzymes. Up to 5% may develop more advanced liver disease variably accompanied by motor neuropathy similar to that seen in the acute porphyrias. Except for the small minority with advanced liver disease, life expectancy is not reduced. The early vesicular lesions in LP can resemble those in EPP. EPP is caused by biallelic pathogenic variants in <italic toggle="yes">FECH</italic> and inherited in an autosomal recessive manner.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="pxe" document-type="chapter"><bold>Pseudoxanthoma elasticum</bold></related-object>
<bold>(PXE)</bold> is a systemic disorder that affects the elastic tissue of the skin, the eye, and the cardiovascular and gastrointestinal systems. Individuals most commonly present with yellowish papules in the skin and/or with angioid streaks of the retina found on routine eye examination or associated with retinal hemorrhage. Occasionally, individuals may present with vascular signs and symptoms, including nephrogenic hypertension, intermittent claudication, angina, gastrointestinal bleeding, myocardial infarct, and stroke. The most frequent cause of morbidity and disability in PXE is reduced vision from macular hemorrhage and disciform scarring of the macula. Some of skin changes on the neck in LP are reminiscent of those in PXE. PXE is caused by biallelic pathogenic variants in <italic toggle="yes">ABCC6</italic> and inherited in an autosomal recessive manner.</p>
      </sec>
      <sec id="lipoid-p.Management">
        <title>Management</title>
        <sec id="lipoid-p.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with lipoid proteinosis (LP), the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Consultation with a dermatologist (or pediatric dermatologist)</p>
            </list-item>
            <list-item>
              <p>Consultation with an otolaryngologist if vocal cord infiltration leads to airway obstruction, recurrent upper respiratory infections, and/or impaired speech</p>
            </list-item>
            <list-item>
              <p>Evaluation for evidence of seizures if clinical findings are suggestive</p>
            </list-item>
            <list-item>
              <p>Evaluation for neuropsychiatric manifestations</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="lipoid-p.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>There is no curative therapy for LP.</p>
          <p><bold>Microlaryngoscopic excision</bold> of laryngeal deposits improves airway access and voice quality [<xref ref-type="bibr" rid="lipoid-p.REF.harper.1983.877">Harper et al 1983</xref>].</p>
          <p><bold>Tracheostomy</bold> on occasion is required to ensure a safe airway in patients with significant airway obstruction [<xref ref-type="bibr" rid="lipoid-p.REF.richards.1973.187">Richards &#x00026; Bull 1973</xref>].</p>
          <p><bold>Seizures</bold> should be assessed and managed by a neurologist, using antiepileptic drugs (AEDs).</p>
          <p><bold>Treatments of unproven efficacy.</bold> Although several reports have described variable success in treatment of skin and vocal cord lesions with dermabrasion, carbon dioxide laser surgery, D-penicillamine, dimethyl sulfoxide (DMSO), corticosteroids, etretinate, acitretin, carbon dioxide laser, and surgical intervention, they are not widely used and their efficacy is unproven. Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lipoid-p-Unproven_Treatments.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for further details.</p>
        </sec>
        <sec id="lipoid-p.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Routine follow up of children to monitor general health as well as psychomotor, emotional, and cognitive development</p>
            </list-item>
            <list-item>
              <p>Monitoring of the airway and vocal cords by an otolaryngologist</p>
            </list-item>
          </list>
        </sec>
        <sec id="lipoid-p.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="lipoid-p.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="lipoid-p.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="lipoid-p.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="lipoid-p.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Lipoid proteinosis (LP) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="lipoid-p.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">ECM1</italic>pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are typically asymptomatic but may have variable findings. <xref ref-type="bibr" rid="lipoid-p.REF.youssefian.2015.220">Youssefian et al [2015]</xref> reported voice hoarseness in cold seasons and thickening of the frenulum and a firm tongue in family members heterozygous for the c.507delT pathogenic variant in <italic toggle="yes">ECM1</italic>.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are typically asymptomatic but may have variable findings. <xref ref-type="bibr" rid="lipoid-p.REF.youssefian.2015.220">Youssefian et al [2015]</xref> reported voice hoarseness in cold seasons and thickening of the frenulum and a firm tongue in family members heterozygous for the c.507delT pathogenic variant in <italic toggle="yes">ECM1</italic>.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Unless an individual with lipoid proteinosis has children with an affected individual or a carrier, his/her offspring will be obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">ECM1</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of an <italic toggle="yes">ECM1</italic>pathogenic variant.</p>
        </sec>
        <sec id="lipoid-p.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">ECM1</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="lipoid-p.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="lipoid-p.Prenatal_Testing_and_Preimplant">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">ECM1</italic> pathogenic variants have been identified in an affected family member, prenatal testing or preimplantation genetic diagnosis for a pregnancy at increased risk for lipoid proteinosis may be options that a couple may wish to consider.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="lipoid-p.Resources">
        <title>Resources</title>
      </sec>
      <sec id="lipoid-p.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="lipoid-p.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Lipoid proteinosis is caused by <italic toggle="yes">ECM1</italic> loss-of-function variants as originally described in six consanguineous families [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2002.833">Hamada et al 2002</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">ECM1</italic> has at least four splice variants: ECM1a, ECM1b, ECM1c, and a short splicing variant. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="lipoid-p" object-id="lipoid-p.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p>ECM1a, the most widely expressed splice variant in various tissues including skin, liver, small intestines, lung, ovary, prostate, testis, skeletal muscle, pancreas, kidney, placenta, and heart, is a transcript from the full-length 10-exon gene, whereas ECM1b lacks exon 7 and ECM1c contains an additional exon 5a sequence within intron 5.</p>
          <p>ECM1b has a much more restricted expression pattern, being detectable only in tonsils and keratinocytes.</p>
          <p>The full pattern of ECM1c expression has yet to be determined; however, in skin it accounts for approximately 15% of total ECM1 RNA [<xref ref-type="bibr" rid="lipoid-p.REF.smits.1997.487">Smits et al 1997</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.smits.2000.718">Smits et al 2000</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.horev.2005.891">Horev et al 2005</xref>].</p>
          <p>The short splicing variant includes 71 bp from the 3&#x02019; end of intron 1 and part of exon 2 to give a truncated 57-amino acid protein with unknown function.</p>
          <p><bold>Pathogenic allelic variants.</bold> Over 50 <italic toggle="yes">ECM1</italic> pathogenic variants have been reported. Although these include missense variants, the majority of inactivating variants are nonsense, frameshift, splice site variants, and large deletions.</p>
          <p>Just over half of all pathogenic variants are located within or in the boundaries of exons 6 or 7 [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2003.345">Hamada et al 2003</xref>].</p>
          <p>Commonly identified pathogenic variants:</p>
          <list list-type="bullet">
            <list-item>
              <p>c.507delT, a frameshift variant, has been reported in individuals from Iran, Thailand, Turkey, India, and Japan [<xref ref-type="bibr" rid="lipoid-p.REF.chan.2007.881">Chan et al 2007</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.youssefian.2015.220">Youssefian et al 2015</xref>]. One individual homozygous for the c.507delT pathogenic variant had skin calcification [<xref ref-type="bibr" rid="lipoid-p.REF.uchida.2007.152">Uchida et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>p.Gln276Ter, a pathogenic nonsense variant in exon 7, is a founder variant and has been reported in more than 30 individuals from South Africa.</p>
            </list-item>
            <list-item>
              <p>c.506dupC is prevalent in individuals of Belgian and Dutch ancestry [<xref ref-type="bibr" rid="lipoid-p.REF.hamada.2002.833">Hamada et al 2002</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.desmet.2005.344">Desmet et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>p.Arg243Ter in exon 7 is prevalent in Italians [<xref ref-type="bibr" rid="lipoid-p.REF.di_giandomenico.2006.162">Di Giandomenico et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>p.Cys220Gly, a pathogenic missense variant in exon 6, has been observed in persons of Chinese ancestry [<xref ref-type="bibr" rid="lipoid-p.REF.zhang.2014.85">Zhang et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Homozygosity for the pathogenic variant p.Gln32Ter in exon 2 has been reported in persons of Libyan and Indian heritage [<xref ref-type="bibr" rid="lipoid-p.REF.chan.2007.881">Chan et al 2007</xref>].</p>
            </list-item>
          </list>
          <table-wrap id="lipoid-p.T.ecm1_pathogenic_variants_disc" position="anchor" orientation="portrait">
            <label>Table 2.</label>
            <caption>
              <p><italic toggle="yes">ECM1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.826C&#x0003e;T<hr/></td>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln276Ter<hr/></td>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004425.3">NM_004425.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004416.2">NP_004416.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.506dupC<break/>(c.501insC)<hr/></td>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro140ProfsTer3<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.727C&#x0003e;T<hr/></td>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg243Ter<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.507delT<hr/></td>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro169ProfsTer8<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.658T&#x0003e;G<hr/></td>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys220Gly<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.93_94delGCinsTT</td>
                  <td headers="hd_h_lipoid-p.T.ecm1_pathogenic_variants_disc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln32Ter</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="lipoid-p.TF.2.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> Extracellular matrix protein 1(ECM1) is a secretory glycoprotein consisting of three major isoforms, ECM1a (540 amino acids), ECM1b (415 amino acids), and ECM1c (559 amino acids).</p>
          <p>ECM1 contains a signal peptide of 19 amino acids followed by four functional domains: a cysteine-free N-terminus, two tandem repeats, and a C-terminus. The latter three domains contain 29 cysteine (C) residues, arranged as CC-(X<sub>7&#x02013;10</sub>)-C motif (X: any amino acid) that is capable of forming protein double loops facilitating protein-protein interactions. ECM1 contains three double-loop domains within latter three domains. The CC-(X<sub>7&#x02013;10</sub>)-C motif may enable ECM1 to serve as a transporter protein or to be involved in binding growth or differentiation factors. ECM1 also contains a calcium-binding domain, which is present in the ECM1a and ECM1c isoforms but not in ECM1b [<xref ref-type="bibr" rid="lipoid-p.REF.smits.1997.487">Smits et al 1997</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.smits.2000.718">Smits et al 2000</xref>, <xref ref-type="bibr" rid="lipoid-p.REF.horev.2005.891">Horev et al 2005</xref>].</p>
          <p><bold>Abnormal gene product.</bold> All reported pathogenic variants are loss-of-function variants and may lead to absence of ECM1protein or production of non-functional protein [<xref ref-type="bibr" rid="lipoid-p.REF.chan.2007.881">Chan et al 2007</xref>].</p>
          <sec id="lipoid-p.Cancer_and_Benign_Tumors">
            <title>Cancer and Benign Tumors</title>
            <p>No correlation between increased cancer incidence and lipoid proteinosis has been reported; however, recently evidence linking expression of ECM1 with aspects of malignancy has emerged as ECM1 is over-expressed in some carcinomas [<xref ref-type="bibr" rid="lipoid-p.REF.wang.2003.57">Wang et al 2003</xref>]. ECM1 has been shown to have an important role in growth, angiogenesis, metastasis, and epithelial-stromal interactions [<xref ref-type="bibr" rid="lipoid-p.REF.lee.2015b.6055">Lee et al 2015b</xref>].</p>
            <p>In contrast, a recent study suggests that ECM1 is a tumor suppressor candidate gene [<xref ref-type="bibr" rid="lipoid-p.REF.gao.2014.533">Gao et al 2014</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="lipoid-p.References">
        <title>References</title>
        <sec id="lipoid-p.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="lipoid-p.Literature_Cited.reflist0">
            <ref id="lipoid-p.REF.belliveau.2015.e150688">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Belliveau</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkhotani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Moniliform blepharosis of lipoid proteinosis.</article-title>
                <source>JAMA Ophthalmol.</source>
                <year>2015</year>
                <volume>133</volume>
                <fpage>e150688</fpage>
                <pub-id pub-id-type="pmid">26158437</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.caccamo.1994.572">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caccamo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Telenta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varela</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiscornia</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis of the small bowel.</article-title>
                <source>Arch Pathol Lab Med.</source>
                <year>1994</year>
                <volume>118</volume>
                <fpage>572</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">7514865</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.chan.2007.881">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sethuraman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1.</article-title>
                <source>Exp Dermatol.</source>
                <year>2007</year>
                <volume>16</volume>
                <fpage>881</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">17927570</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.chan.2004.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>South</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhogal</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Rapid diagnosis of lipoid proteinosis using an anti-extracellular matrix protein 1 (ECM1) antibody.</article-title>
                <source>J Dermatol Sci.</source>
                <year>2004</year>
                <volume>35</volume>
                <fpage>151</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15265527</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.claeys.2007.465">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Claeys</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Goethem</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sercu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merregaert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Marck</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parizel</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Epilepsy and migraine in a patient with Urbach-Wiethe disease.</article-title>
                <source>Seizure.</source>
                <year>2007</year>
                <volume>16</volume>
                <fpage>465</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17403608</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.cust_dio_lima.2014">
              <mixed-citation publication-type="other">Cust&#x000f3;dio Lima J, Nagasako CK, Montes CG, Barcelos IH, de Carvalho RB, Mesquita MA. Gastrointestinal involvement in lipoid proteinosis: a ten-year follow-up of a Brazilian female patient. Case Rep Med. 2014;2014:952038.</mixed-citation>
            </ref>
            <ref id="lipoid-p.REF.desmet.2005.344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Desmet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devos</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dhooge</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naeyaert</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and molecular abnormalities in lipoid proteinosis.</article-title>
                <source>Eur J Dermatol.</source>
                <year>2005</year>
                <volume>15</volume>
                <fpage>344</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16172042</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.di_giandomenico.2006.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Giandomenico</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassandrini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Hachem</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vito</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis: case report and review of the literature.</article-title>
                <source>Acta Otorhinolaryngol Ital.</source>
                <year>2006</year>
                <volume>26</volume>
                <fpage>162</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17063986</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.gao.2014.533">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma.</article-title>
                <source>Genome Biol.</source>
                <year>2014</year>
                <volume>15</volume>
                <fpage>533</fpage>
                <pub-id pub-id-type="pmid">25517360</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.gon_alves.2010.88">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gon&#x000e7;alves</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Melo</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>del Matos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barra</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <article-title>Amygdalae and striatum calcification in lipoid proteinosis.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>88</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">19696137</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.hamada.2002.833">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsay</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edelstein</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>South</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleck</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallipeddi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopping-Hepenstal</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittock</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munro</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steijlen</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1).</article-title>
                <source>Hum Mol Genet.</source>
                <year>2002</year>
                <volume>11</volume>
                <fpage>833</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">11929856</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.hamada.2003.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>South</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siriwattana</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jewhasuchin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charuwichitratana</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thappa</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeevankumar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenane</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krafchik</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulthanan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaya</surname>
                    <given-names>TI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdal</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paradisi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paller</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seishima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2003</year>
                <volume>120</volume>
                <fpage>345</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">12603844</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.hamada.2002.624">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis.</article-title>
                <source>Clin Exp Dermatol.</source>
                <year>2002</year>
                <volume>27</volume>
                <fpage>624</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12472532</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.harper.1983.877">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duguid</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staughton</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moffat</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <article-title>Oropharyngeal and laryngeal lesions in lipoid proteinosis.</article-title>
                <source>J Laryngol Otol.</source>
                <year>1983</year>
                <volume>97</volume>
                <fpage>877</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">6886551</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.horev.2005.891">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horev</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potikha</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayalon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molho-Pessach</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ingber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gany</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edin</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glaser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zlotogorski</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A novel splice-site mutation in ECM-1 gene in a consanguineous family with lipoid proteinosis.</article-title>
                <source>Exp Dermatol.</source>
                <year>2005</year>
                <volume>14</volume>
                <fpage>891</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16274456</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.lee.2015b.6055">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nam</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shim</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahn</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>ECM1 regulates tumor metastasis and CSC-like property through stabilization of &#x003b2;-catenin.</article-title>
                <source>Oncogene.</source>
                <year>2015b</year>
                <volume>34</volume>
                <fpage>6055</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">25746001</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.lee.2015a.608">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duo</surname>
                    <given-names>LN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hua</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>ZM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis resulting from a large homozygous deletion affecting part of the ECM1 gene and adjacent long non-coding RNA.</article-title>
                <source>Acta Derm Venereol.</source>
                <year>2015a</year>
                <volume>95</volume>
                <fpage>608</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">25518807</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.messina.2012.1740">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuzzaco</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbieri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarlato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerevini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sessa</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Spontaneous intracerebral hemorrhage in Urbach-Wiethe disease.</article-title>
                <source>Neurology.</source>
                <year>2012</year>
                <volume>79</volume>
                <fpage>1740</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">23035073</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.moy.1987.1193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moy</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moy</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuoka</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis: ultrastructural and biochemical studies.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>1987</year>
                <volume>16</volume>
                <fpage>1193</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">2439554</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.richards.1973.187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bull</surname>
                    <given-names>PD</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis of the larynx.</article-title>
                <source>J Laryngol Otol.</source>
                <year>1973</year>
                <volume>87</volume>
                <fpage>187</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">4687163</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.savage.1988.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Savage</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crockett</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCabe</surname>
                    <given-names>BF</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis of the larynx: a cause of voice change in the infant and young child.</article-title>
                <source>Int J Pediatr Otorhinolaryngol.</source>
                <year>1988</year>
                <volume>15</volume>
                <fpage>33</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">3372140</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.siebert.2003.2627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siebert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markowitsch</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartel</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease.</article-title>
                <source>Brain.</source>
                <year>2003</year>
                <volume>126</volume>
                <fpage>2627</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">12937075</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.smits.1997.487">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smits</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wauters</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutaibi</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dillon</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merregaert</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization.</article-title>
                <source>Genomics.</source>
                <year>1997</year>
                <volume>45</volume>
                <fpage>487</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">9367673</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.smits.2000.718">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smits</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poumay</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karperien</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tylzanowski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wauters</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huylebroeck</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponec</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merregaert</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2000</year>
                <volume>114</volume>
                <fpage>718</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">10733679</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.teive.2013.1720">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teive</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruschel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munhoz</surname>
                    <given-names>RP</given-names>
                  </name>
                </person-group>
                <article-title>Spontaneous intracerebral hemorrhage in Urbach-Wiethe disease.</article-title>
                <source>Neurology.</source>
                <year>2013</year>
                <volume>80</volume>
                <fpage>1720</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">23628933</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.thornton.2008.86">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thornton</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nel</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thornton</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Honk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <article-title>The neuropsychiatry and neuropsychology of lipoid proteinosis.</article-title>
                <source>J Neuropsychiatry Clin Neurosci.</source>
                <year>2008</year>
                <volume>20</volume>
                <fpage>86</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">18305289</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.uchida.2007.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uchida</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inaoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>W.</given-names>
                  </name>
                </person-group>
                <article-title>A failure of mucocutaneous lymphangiogenesis may underlie the clinical features of lipoid proteinosis.</article-title>
                <source>Br J Dermatol.</source>
                <year>2007</year>
                <volume>156</volume>
                <fpage>152</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17199583</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.van_hougenhoucktulleken.2004.413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Hougenhouck-Tulleken</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thornton</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsay</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa.</article-title>
                <source>Br J Dermatol.</source>
                <year>2004</year>
                <volume>151</volume>
                <fpage>413</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">15327549</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.wang.2003.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>XM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ning</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pei</surname>
                    <given-names>XF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Underhill</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liekens</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merregaert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors.</article-title>
                <source>Cancer Lett.</source>
                <year>2003</year>
                <volume>200</volume>
                <fpage>57</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">14550953</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.youssefian.2015.220">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Youssefian</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahidnezhad</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daneshpazhooh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdollahzadeh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talari</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khoshnevisan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chams-Davatchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mobasher</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akhondzadeh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabrizi</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Lipoid proteinosis: phenotypic heterogeneity in Iranian families with c.507delT mutation in ECM1.</article-title>
                <source>Exp Dermatol.</source>
                <year>2015</year>
                <volume>24</volume>
                <fpage>220</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">25529926</pub-id>
              </element-citation>
            </ref>
            <ref id="lipoid-p.REF.zhang.2014.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Cai T1, Wang Q. Treatment of lipoid proteinosis due to the p.C220G mutation in ECM1, a major allele in Chinese patients.</article-title>
                <source>J Transl Med.</source>
                <year>2014</year>
                <volume>12</volume>
                <fpage>85</fpage>
                <pub-id pub-id-type="pmid">24708644</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="lipoid-p.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="lipoid-p.Author_Notes">
          <title>Author Notes</title>
          <p><bold>Jouni Uitto</bold>, MD, PhD, has been Professor of Dermatology and Cutaneous Biology, and Biochemistry and Molecular Biology, and Chair of the Department of Dermatology and Cutaneous Biology at The Sidney Kimmel Medical College at Thomas Jefferson University, in Philadelphia, Pennsylvania, since 1986. He is also Director of the Jefferson Institute of Molecular Medicine at Thomas Jefferson University. He received his MD and PhD degrees from the University of Helsinki, Finland, and completed his residency training in dermatology at Washington University School of Medicine, St. Louis, Missouri. Dr. Uitto is internationally recognized for his research on connective tissue biology and molecular genetics in relation to cutaneous diseases. Dr. Uitto&#x02019;s publications include 665 original articles in peer-reviewed journals, 314 textbook chapters and review articles, and 965 abstracts on presentations in national and international meetings. Dr. Uitto has been the recipient of numerous national and international awards, including honorary doctorate degrees from the University of Kuopio, University of Oulu, and University of Turku, all in Finland, as well as honorary professorship at China Medical University, Shenyang, Hebei United University, Tangshan, and The Fourth Military Medical University, Xi&#x02019;an, all in China. Dr. Uitto has held office in several scientific and professional societies, including as President of the Society for Investigative Dermatology and President and Chairman of the Board of Trustees of Dermatology Foundation. Dr. Uitto is also Section Editor of the Journal of Investigative Dermatology and Associate Editor of the American Journal of Pathology; he is on the editorial boards of numerous peer-reviewed journals.</p>
          <p><bold>Hassan Vahidnezhad</bold> and <bold>Leila Youssefian</bold> are PhD candidates in medical genetics working on genodermatoses at Sidney Kimmel Medical college of Thomas Jefferson University in Philadelphia, Pennsylvania<bold>.</bold></p>
          <p>Leila Youssefian and Hassan Vahidnezhad contributed equally to this work.</p>
        </sec>
        <sec id="lipoid-p.Acknowledgments">
          <title>Acknowledgments</title>
          <p>Carol Kelly assisted in manuscript preparation.</p>
        </sec>
        <sec id="lipoid-p.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>21 January 2016 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>28 July 2015 (ju) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="lipoid-p.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Clinical appearances of lipoid proteinosisa. Vesicles and hemorrhagic crusts and scars on the faceb. Hyperkeratotic wart-like or nodular lesions on the fingersc. Reduced tongue movement due to thickening of the sub-lingual frenulumd, e. Papular thickening of the upper and lower eyelids, moniliform blepharosisf. Warty skin thickening and infiltration on the elbowg. Warty nodules over infiltrated plaques on kneesh. Axial CT showing bilateral symmetric amygdalae calcifications.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lipoid-p-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
